Please enable JavaScript to continue using this application.

Compare $RCKT vs $ZSQR | Chartloom

Compare

$RCKT vs $ZSQR

Rocket Pharmaceuticals Inc · Z Squared Inc (Delaware)

RCKT

Rocket Pharmaceuticals Inc

ZSQR

Z Squared Inc (Delaware)

Compare $RCKT vs $ZSQR

Comparing Rocket Pharmaceuticals Inc and Z Squared Inc (Delaware)

RCKTRocket Pharmaceuticals Inc

ZSQRZ Squared Inc (Delaware)

RCKTRocket Pharmaceuticals Inc

Market cap

$280M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

34.18x

Rev growth (TTM)

—

YTD performance

-26.0%

52W performance

-24.5%

FCF yield

-61.0%

ZSQRZ Squared Inc (Delaware)

Market cap

$298M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

961.0%

YTD performance

-62.8%

52W performance

-62.8%

FCF yield

-1.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RCKT

ZSQR

Detailed metrics comparison

RCKT

Rocket Pharmaceuticals Inc

ZSQR

Z Squared Inc (Delaware)

Market Cap

RCKT$280M

ZSQR$298M

Enterprise Value

RCKT$76M

ZSQR$283M

Price

RCKT$2.56

ZSQR$5.66

P/E Ratio

RCKTN/A

ZSQRN/A

P/S Ratio

RCKT0.00x

ZSQR106.71x

EV/Sales

RCKT0.00x

ZSQR101.17x

EV/EBITDA

RCKT8.60x

ZSQR0.00x

P/B Ratio

RCKT0.76x

ZSQR1.36x

P/FCF Ratio

RCKTN/A

ZSQRN/A

EV/FCF

RCKT-0.45x

ZSQR-69.99x

PEG Ratio

RCKTN/A

ZSQRN/A

Forward P/E (NTM)

RCKTN/A

ZSQRN/A

Forward P/S (NTM)

RCKT34.18x

ZSQRN/A

Revenue (TTM)

RCKT$0

ZSQR$3M

Revenue Growth (YoY)

RCKTN/A

ZSQR961.0%

Forward Rev Growth

RCKT833.4%

ZSQR0.0%

Gross Margin (TTM)

RCKT0.0%

ZSQR-24.6%

Operating Margin (TTM)

RCKT0.0%

ZSQR0.0%

EBITDA Margin (TTM)

RCKT0.0%

ZSQR-712.5%

Net Margin (TTM)

RCKT0.0%

ZSQR-785.1%

FCF Margin (TTM)

RCKTN/A

ZSQR-144.6%

Net Income (TTM)

RCKT$-17M

ZSQR$-22M

FCF (TTM)

RCKT$-171M

ZSQR$-4M

EPS (TTM)

RCKT-$0.15

ZSQR-$0.44

ROE (TTM)

RCKT-576.0%

ZSQR-5059.0%

ROA (TTM)

RCKT-490.0%

ZSQR-4757.0%

ROIC (TTM)

RCKT-538.0%

ZSQR-5038.0%

Cash

RCKT$225M

ZSQR$15M

Debt

RCKT$21M

ZSQR$0

Net Cash/Debt

RCKT$203M

ZSQR$15M

Current Ratio (TTM)

RCKT9.24x

ZSQR7.66x

Quick Ratio (TTM)

RCKT9.06x

ZSQR7.64x

Debt/Equity (TTM)

RCKT0.06x

ZSQR0.02x

Debt/Assets (TTM)

RCKT0.0%

ZSQR0.0%

Interest Coverage (TTM)

RCKTN/A

ZSQRN/A

Net Debt/EBITDA (TTM)

RCKT0.00x

ZSQR0.00x

Beta

RCKT0.48

ZSQRN/A

52W Performance

RCKT-24.5%

ZSQR-62.8%

YTD Performance

RCKT-26.0%

ZSQR-62.8%

% from 52W High

RCKT-53.0%

ZSQR-69.9%

% from 52W Low

RCKT5.8%

ZSQR168.2%

Asset Turnover (TTM)

RCKT0.00x

ZSQR0.06x

FCF Yield (TTM)

RCKT-61.0%

ZSQR-1.4%

Earnings Yield (TTM)

RCKT-6.2%

ZSQR-7.4%

Dividend Yield (TTM)

RCKTN/A

ZSQRN/A

Rule of 40

RCKT0.0

ZSQR816.4

EV/GP/RG

RCKTN/A

ZSQRN/A

Ticker research

View RCKT research View ZSQR research

Metric	RCKT Rocket Pharmaceuticals Inc	ZSQR Z Squared Inc (Delaware)
Market & Valuation
Market Cap	$280M	$298M
Enterprise Value	$76M	$283M
Price	$2.56	$5.66
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	106.71x
EV/Sales	0.00x	101.17x
EV/EBITDA	8.60x	0.00x
P/B Ratio	0.76x	1.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.45x	-69.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.18x	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	961.0%
Forward Rev Growth	833.4%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-24.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-712.5%
Net Margin (TTM)	0.0%	-785.1%
FCF Margin (TTM)	N/A	-144.6%
Net Income (TTM)	$-17M	$-22M
FCF (TTM)	$-171M	$-4M
EPS (TTM)	-$0.15	-$0.44
ROE (TTM)	-576.0%	-5059.0%
ROA (TTM)	-490.0%	-4757.0%
ROIC (TTM)	-538.0%	-5038.0%
Financial Health
Cash	$225M	$15M
Debt	$21M	$0
Net Cash/Debt	$203M	$15M
Current Ratio (TTM)	9.24x	7.66x
Quick Ratio (TTM)	9.06x	7.64x
Debt/Equity (TTM)	0.06x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.48	N/A
52W Performance	-24.5%	-62.8%
YTD Performance	-26.0%	-62.8%
% from 52W High	-53.0%	-69.9%
% from 52W Low	5.8%	168.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-61.0%	-1.4%
Earnings Yield (TTM)	-6.2%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	816.4
EV/GP/RG	N/A	N/A
Ticker research	View RCKT research	View ZSQR research

Valuation

P/S Ratio

RCKT

0.00x

ZSQR

106.71x

EV/FCF

ZSQR

-69.99x

RCKT

-0.45x

Growth & revenue

Revenue Growth TTM

ZSQR

961.0%

Forward Revenue Growth

RCKT

833.4%

ZSQR

0.0%

Profitability & performance

Gross Margin

RCKT

0.0%

ZSQR

-24.6%

ROE

RCKT

-576.0%

ZSQR

-5059.0%

FCF Yield %

ZSQR

-1.4%

RCKT

-61.0%

52-Week Performance

RCKT

-24.5%

ZSQR

-62.8%

Detailed metrics comparison

RCKT

Rocket Pharmaceuticals Inc

ZSQR

Z Squared Inc (Delaware)

Market Cap

RCKT$280M

ZSQR$298M

Enterprise Value

RCKT$76M

ZSQR$283M

Price

RCKT$2.56

ZSQR$5.66

P/E Ratio

RCKTN/A

ZSQRN/A

P/S Ratio

RCKT0.00x

ZSQR106.71x

EV/Sales

RCKT0.00x

ZSQR101.17x

EV/EBITDA

RCKT8.60x

ZSQR0.00x

P/B Ratio

RCKT0.76x

ZSQR1.36x

P/FCF Ratio

RCKTN/A

ZSQRN/A

EV/FCF

RCKT-0.45x

ZSQR-69.99x

PEG Ratio

RCKTN/A

ZSQRN/A

Forward P/E (NTM)

RCKTN/A

ZSQRN/A

Forward P/S (NTM)

RCKT34.18x

ZSQRN/A

Revenue (TTM)

RCKT$0

ZSQR$3M

Revenue Growth (YoY)

RCKTN/A

ZSQR961.0%

Forward Rev Growth

RCKT833.4%

ZSQR0.0%

Gross Margin (TTM)

RCKT0.0%

ZSQR-24.6%

Operating Margin (TTM)

RCKT0.0%

ZSQR0.0%

EBITDA Margin (TTM)

RCKT0.0%

ZSQR-712.5%

Net Margin (TTM)

RCKT0.0%

ZSQR-785.1%

FCF Margin (TTM)

RCKTN/A

ZSQR-144.6%

Net Income (TTM)

RCKT$-17M

ZSQR$-22M

FCF (TTM)

RCKT$-171M

ZSQR$-4M

EPS (TTM)

RCKT-$0.15

ZSQR-$0.44

ROE (TTM)

RCKT-576.0%

ZSQR-5059.0%

ROA (TTM)

RCKT-490.0%

ZSQR-4757.0%

ROIC (TTM)

RCKT-538.0%

ZSQR-5038.0%

Cash

RCKT$225M

ZSQR$15M

Debt

RCKT$21M

ZSQR$0

Net Cash/Debt

RCKT$203M

ZSQR$15M

Current Ratio (TTM)

RCKT9.24x

ZSQR7.66x

Quick Ratio (TTM)

RCKT9.06x

ZSQR7.64x

Debt/Equity (TTM)

RCKT0.06x

ZSQR0.02x

Debt/Assets (TTM)

RCKT0.0%

ZSQR0.0%

Interest Coverage (TTM)

RCKTN/A

ZSQRN/A

Net Debt/EBITDA (TTM)

RCKT0.00x

ZSQR0.00x

Beta

RCKT0.48

ZSQRN/A

52W Performance

RCKT-24.5%

ZSQR-62.8%

YTD Performance

RCKT-26.0%

ZSQR-62.8%

% from 52W High

RCKT-53.0%

ZSQR-69.9%

% from 52W Low

RCKT5.8%

ZSQR168.2%

Asset Turnover (TTM)

RCKT0.00x

ZSQR0.06x

FCF Yield (TTM)

RCKT-61.0%

ZSQR-1.4%

Earnings Yield (TTM)

RCKT-6.2%

ZSQR-7.4%

Dividend Yield (TTM)

RCKTN/A

ZSQRN/A

Rule of 40

RCKT0.0

ZSQR816.4

EV/GP/RG

RCKTN/A

ZSQRN/A

Ticker research

View RCKT research View ZSQR research

Metric	RCKT Rocket Pharmaceuticals Inc	ZSQR Z Squared Inc (Delaware)
Market & Valuation
Market Cap	$280M	$298M
Enterprise Value	$76M	$283M
Price	$2.56	$5.66
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	106.71x
EV/Sales	0.00x	101.17x
EV/EBITDA	8.60x	0.00x
P/B Ratio	0.76x	1.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.45x	-69.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.18x	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	961.0%
Forward Rev Growth	833.4%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-24.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-712.5%
Net Margin (TTM)	0.0%	-785.1%
FCF Margin (TTM)	N/A	-144.6%
Net Income (TTM)	$-17M	$-22M
FCF (TTM)	$-171M	$-4M
EPS (TTM)	-$0.15	-$0.44
ROE (TTM)	-576.0%	-5059.0%
ROA (TTM)	-490.0%	-4757.0%
ROIC (TTM)	-538.0%	-5038.0%
Financial Health
Cash	$225M	$15M
Debt	$21M	$0
Net Cash/Debt	$203M	$15M
Current Ratio (TTM)	9.24x	7.66x
Quick Ratio (TTM)	9.06x	7.64x
Debt/Equity (TTM)	0.06x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.48	N/A
52W Performance	-24.5%	-62.8%
YTD Performance	-26.0%	-62.8%
% from 52W High	-53.0%	-69.9%
% from 52W Low	5.8%	168.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-61.0%	-1.4%
Earnings Yield (TTM)	-6.2%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	816.4
EV/GP/RG	N/A	N/A
Ticker research	View RCKT research	View ZSQR research